Tag Archive for: Captiva Spine

Captiva Spine WatchTower Spine Navigation First Case in US using enabling technology

Captiva Spine WatchTower Spine Navigation First Case in US using enabling technology

WatchTower™ Spine Navigation and Robotics: Sophisticated 2D Registration Algorithm Eliminates the Need for Intraoperative 3D Imaging

Captiva Spine, a spinal technology organization dedicated to providing clinical and economical solutions in spine care, announced the completion of the first U.S. cases series using their new state-of-the-art WatchTower Spine Navigation System. The surgeries were performed by Dr. Hunaldo Villalobos of the Central Florida Neurosurgery Institute at facilities in the Orlando, FL, area.

The WatchTower Spine Navigation and Robotics Systems streamline the surgical workflow by merging a pre-operative CT scan with 2D imaging using a sophisticated algorithm to provide real-time 3D images of the patient’s spine during surgery. This allows the surgeon to navigate the spine with enhanced accuracy and precision, intended to improve patient outcomes and reduce the risk of complications. Additionally, the system eliminates the need for intraoperative 3D imaging for registration, minimizing operative time and radiation exposure for patients and staff and enhancing the safety and efficiency of spine surgeries.

“A fast, accurate, and inexpensive system makes navigation equipment installation at an ambulatory surgery center (ASC) feasible.”

“Captiva Spine’s WatchTower will be a game-changer for facilities doing spine surgery.” Said Dr. Hundaldo Villalobos.  “The system’s ability to register without relying on intraoperative CT scans or surface mapping through an open exposure makes it highly efficient and able to transform procedural workflow.” Dr. Villalobos further mentioned, “Speed of workflow was very impressive, including a decrease of set up time and implementation for the entire staff. Having a fast, accurate, and inexpensive system makes navigation equipment installation at an ambulatory surgery center (ASC) feasible.”

Dale Mitchell, President of Captiva Spine, expressed excitement over the first US cases with the WatchTower Spine Navigation System, stating, “We are thrilled to see our technology making a real impact in the operating room. Our team has worked tirelessly to bring this system to market and ensure its sophisticated technology is still practical and easy to use.  This milestone reinforces our vision of providing clinical and economical solutions to the market.”

Get Enabling Technology in Your Facility

WatchTower Spine Navigation System US placements will be available by the end of 2Q23. For more information about the Captiva Spine WatchTower Spine Navigation and Robotics System and our other spinal fusion solutions, please visit www.captivaspine.com/spine-navigation

__________

To take advantage of Captiva Spine’s innovative technologies and incorporate them into your healthcare offerings, please don’t hesitate to contact us. We welcome inquiries from healthcare providers, surgical facilities, and distribution professionals. To get in touch with us directly, please email our team at info@captivaspine.com

About Captiva Spine, Inc. 

Captiva Spine, founded in 2007, is a privately held medical device company that brings healthcare providers, distribution professionals, and surgical facilities together with innovative spinal care solutions. With a focus on quality, Captiva Spine strives to create reliable systems that provide clinical and economical solutions to the spine market.

Captiva Spine – Navigating Today.

__________

Daniel McPhillips
Director of Enabling Technologies & Market Development
561-277-9480 ext. 706

This Press Release is also featured on: PrWeb.com, OrthoSpineNews.com, Orthoworld.com, Spine-Market.com, SPINEMarketGroup           


real-time 3D spine navigation and robotics

watchtower spine navigation and robotics for MIS spine surgery

WatchTower™ Spine Navigation and Robotics: Expanding Management Team

Captiva Spine is a medical device organization located in Jupiter, Florida, dedicated to delivering smart, elegant, and intuitive spinal fusion solutions. Today Captiva Spine announced the expansion of its management team to accelerate the roll-out of its WatchTower Spine Navigation and Robotic System. Daniel McPhillips has joined Captiva Spine as the Director of Enabling Technologies and Market Development. “Dan will be a great asset to the roll-out of the WatchTower Spine Navigation and Robotics System,” said Dale Mitchell, President of Captiva Spine. “Dan has been at the forefront of numerous technological inflection points in the spine market going back to the first MIS pedicle screw systems and cage IDE/PMAs. His most recent experience focused on innovations in percutaneous interbody fusion.”

The WatchTower Spine Navigation System promises to provide surgeons with a next-generation navigation and robotics system for the Ambulatory Surgery Center (ASC) and specialty hospital. WatchTower Spine Navigation eliminates the need for inter-operative CT imagery. This offers exceptional procedural efficiency, radiation safety, and a cost-effective navigation solution for these new service sites. The spine navigation system has received 510(k) clearance from the FDA (U.S. Food and Drug Administration) and is available for commercial use.

The WatchTower Spine Navigation and Robotics System eliminates the need for intraoperative CT imagery. This offers exceptional procedural efficiency, radiation safety, and cost-effective navigation…

“Spinal fusion procedures have become less invasive and post-operative significantly more effective, making same-day lumbar fusion surgery a reality,” said Dan McPhillips. “This, along with the recent changes in the CMS in-patient-only list, makes ASC MIS spinal fusion a real opportunity for surgeons and patients. I am excited to join Captiva because the WatchTower Spine Navigation and Robotics System offer advanced spine navigation capabilities yet are economically practical for the ASC setting.”

Vertical Integration at Captiva Spine

“At Captiva Spine, we always strive to provide smart, elegant, and intuitive spinal solutions, but more than that, we are working to provide a solid vertically integrated procedural platform,” said Dale Mitchell. The WatchTower System is a synergistic addition to support our newest generation TowerLOX-EXT MIS Extended Tab Pedicle Screw System and TransFasten Posterior SI Joint Fusion System.

TowerLOX-EXT is the next-generation extended tab MIS screw system from Captiva Spine. It affords the surgeon the state-of-the-art MIS extended tab design they expect with significantly more reduction and spinal re-alignment utility than other systems on the market. 

The TransFasten Posterior SI Fusion System is a unique approach to posterior MIS sacroiliac joint fusions, offering increased efficiency while reducing the invasiveness of traditional sacroiliac joint fusions. The system’s patented carpentry has been developed to ensure ease of use, immediate stabilization of the motion segment, and an optimal environment for fusion. Experience the benefits of TransFasten for yourself and discover how our innovative system may help achieve the results patients are looking for.

__________

To take advantage of Captiva Spine’s innovative technologies and incorporate them into your healthcare offerings, please don’t hesitate to reach out to us. We welcome inquiries from healthcare providers, surgical facilities, and distribution professionals. To get in touch with us directly, please email our team at info@captivaspine.com

See More Details

About Captiva Spine, Inc. 

Captiva Spine, founded in 2007, is a privately owned medical device company that brings healthcare providers, distribution professionals, and surgical facilities together with innovative spinal care solutions. With a focus on quality, Captiva Spine strives to build and maintain sincere, honest, and collaborative relationships to earn mutual trust and openness. By doing so, we aim to become the preferred provider of smart, elegant, and intuitive spine care solutions.
__________

Daniel McPhillips
Director of Enabling Technologies & Market Development
561-277-9480 ext. 706

This Press Release is also featured on: PrWeb.com, SpineMarketGroup, Spine-Market.com,  OrthoSpineNews, Becker’s Spine Review,                     


real-time 3D spine navigation and robotics

Spine Navigation and Robotics: Exclusive Strategic Partnership 

Captiva Spine is a medical device organization located in Jupiter, Florida, dedicated to delivering smart, elegant, and intuitive spinal fusion solutions. They announced today its long-term exclusive strategic partnership with REMEX Medical, a developer of advanced navigation and robotics technologies located in Taichung, Taiwan; for real-time 3D spine navigation with future developments in practical robotic solutions.

Captiva Spine looks forward to serving the substantial demand and need for both navigation and surgical robots for spinal applications. For underserved hospitals and Ambulatory Surgery Centers (ASCs) throughout the U.S., this technology will serve as a platform to expand the company’s products and services with enhanced enabling technology to support MIS technology.  Specifically, Captiva Spine will be starting with their CapLOX Pedicle Screws, TowerLOX-EXT MIS Extended Tab Pedicle Screws, and TransFasten Posterior SI joint fusion system.

Future Developments in Spine Navigation and Robotics

Nelson Lin, CEO of REMEX Medical, said, “we are very pleased to enter the US marketplace with our new strategic partner, Captiva Spine. We share an enthusiasm and commitment to providing ongoing advancements for the betterment of spine care. REMEX has been researching and developing this platform for eight years with proven clinical performance.”

The navigation system has 510(k) clearance from the FDA ( U.S. Food and Drug Administration) and is available for commercial use. The navigation unit is a small on-site unit for more facilities looking to take advantage of the benefits of readily available, easy-to-use spine navigation. This model offers physicians, orthopedics, and neurosurgeons easy-to-use, cutting-edge technology to pre-plan and visualize their surgical approach. This platform utilizes preoperative CT scans and rapid intraoperative registration for accurate real-time 3D navigation with limited radiation exposure to staff and patients.

Cost-Effective, Real-Time 3D Navigation and Robotics that’s user-friendly

The spine navigation platform will be demonstrated at Captiva Spine’s booth (#3731) at the 2022 North American Spine Society (NASS) Annual Meeting, in Chicago, IL, October 12-14.

“This platform for spine navigation helps fulfill our commitment to being a clinical and economical solution with advanced enabling technology for spine care,” said Dale Mitchell, President of Captiva Spine. “We plan to have a technically advanced navigation platform to improve spine procedural efficiency and be economically feasible for the growing number of ASCs and specialty hospitals throughout the United States,” Mitchell continued.

Improving and Expanding the Spine Navigation Platform

Spine Navigation allows surgeons to oversee the precise placement of MIS pedicle screws while situated directly at the operation site, guided by navigation technology. “Our goal is to provide a technology for reproducibility of screw accuracy and placement with higher confidence and safety in difficult areas is also a goal in mind, as well as improving screw insertion times, especially in cases of difficult anatomy,” said Mitchell.

Captiva Spine is planning to expand the system’s capabilities to include robotics. Both platforms are intended to improve the reproducibility and accuracy of applicable procedures to meet the growing demand for enabling solutions worldwide.

Inquiries from physicians and industry professionals looking to incorporate intelligent and innovative technologies into their offerings are always welcome. Captiva Spine can be contacted directly by phone at 561-277-9480. 

See More Details

About Captiva Spine, Inc. 

Captiva Spine is a privately owned medical device organization founded in 2007.  Captiva Spine supports spine surgeons, tenured spine distributors, and healthcare facilities.  In providing patients with progressive spinal care and an obsessive focus on quality, they strive to create and maintain sincere, honest, collaborative relationships. Valuing their relationships fosters the mutual trust and openness needed for Captiva Spine to be a conduit of high-quality, smart, elegant, and intuitive patient solutions. Captiva Spine operates as a family of industry professionals that take pride in delivering these solutions responsibly and ethically. While never losing sight of what they refer to as the Human Factor, they find joy in their daily lives and serve the needs of their customers with sincere, professional enthusiasm.


TransFasten Posterior SI Fusion System Quadracentric Sacroiliac Joint Site Preparation

TransFasten Posterior SI Fusion System Quadracentric Sacroiliac Joint Site Preparation

TransFasten® Posterior SI  Fusion System 

Captiva Spine, Inc., developer and distributor of intuitive spine fusion devices, announced today they received “Notice of Allowance by the United States Patent and Trademark Office (USPTOfor their patent on a novel posterior sacroiliac (SI) joint fusion System named TransFastenSpecifically, the system’s precision form of Quadracentric carpentry which prepares the sacroiliac joint intended for an easy, safe, and repeatable SI joint fusion surgery.  

Recognizing the growing adoption of SI fusion procedures, we are committed to the continued development of differentiated and proprietary devices that clearly provide incremental improvement. This patent marks another milestone for Captiva Spine’s growing patent portfolio,” said Dale Mitchell, President of Captiva Spine. TransFasten’s form of carpentry is truly aligned with key principles of achieving ease of use, stabilization, and fusion while utilizing a safe posterior approach. 

Posterior SI Joint Fusion – Proprietary Technique

TransFasten Posterior SI Fusion System Quadracentric Sacroiliac Joint Site Preparation

“…many will bring this procedure to their practice simply for the safety of the posterior approach coupled with this unique approach to SI joint fusion site preparation.

The TransFasten technique is intended to provide stabilization of the SI joint, with minimal disruption to anatomy, in a minimally invasive procedure. This patented Quadracentric site preparation is a form of mortise and tenon carpentry and requires one implant; many other systems require multiple implants or large screws.  TransFasten is a precision-machined allograft with a large graft window that precisely fits within the sizeable cross-joint decortication for creating biologic fusion. This posterior procedure provides a safe approach to dock minimal instrumentation. It prepares the SI joint sitwhich includes the richest proliferation of osteogenic cells while placing the implant in a predetermined position Altogether, TransFasten may potentially reducoperating room and fluoroscopy time.  

As Captiva Spine continues to introduce TransFasten, many will bring this procedure to their practice simply for the safety of the posterior approach coupled with this unique approach to SI joint fusion site preparation, said Dr. Robert E. Lins, The Center for the Bone & Joint Surgery, and inventor of TransFasten. Because the sacroiliac joints transfer forces from the upper body to the lower extremities, they are subject to trauma and chronic degenerative changes. I truly believe the TransFasten procedure will enable the medical community to better serve their patients suffering these degenerative changes in the future.”  

Inquiries from physicians and industry professionals looking to incorporate intelligent and innovative technologies into their offerings are always welcome. Captiva Spine can be contacted directly by phone at 561-277-9480. 

See how TransFasten works

Reach out to schedule training and clinical support with a company representative

About Captiva Spine, Inc. 

Captiva Spine is a privately-owned medical device organization founded in 2007.  Captiva Spine supports spine surgeons, tenured spine distributors, and healthcare facilities in providing patients with progressive spinal care and an obsessive focus on quality; they strive to create and maintain sincere, honest, collaborative relationships. Above all else, valuing their relationships fosters the mutual trust and openness needed for Captiva Spine to be a conduit of high quality, smart, elegant, and intuitive patient solutions. Captiva Spine operates as a family of industry professionals that take pride in delivering these solutions responsibly and ethically while never losing sight of what they refer to as the Human FactorFinding joy in their daily lives and serving the needs of their customers with sincere, professional enthusiasm. 


This press release can also be found on OrthoSpineNews.com, OrthoWorld.com, Spine-Market.com, TheSpineMarketGroup.com, PRweb.com

TirboLOX Top View - 50x

TirboLOX-C Titanium Cervical CageCaptiva Spine Adds Cervical Cages to TirboLOX™ Dual Layer Lattice Structure 3D Printed Titanium Cage Offering

Jupiter, FL, August 2018 – Captiva Spine is a medical device organization located in Jupiter, Florida, dedicated to delivering smart, elegant and intuitive spinal fusion solutions. Today, Captiva Spine is announcing it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its TirboLOX-C 3D Printed Titanium Cervical Cages.

TirboLOX-C Titanium Cervical Cages

TirboLOX-C Titanium Cervical Cages were created following the principles of biomimicry.   The titanium alloy interbody fusion devices with a dual layer organic lattice structure are formed using advanced 3D printing technologies. This lattice structure features a micro-rough surface topography, interconnected dual porosity, and open architecture.  Titanium alloy implants with micro-rough surface topographies and dual porosity have been shown to promote direct bony on growth, in growth and vascularization. TirboLOX-C’s open architecture is designed to reduce radiographic presence for clear imaging.  TirboLOX-C’s high coefficient of friction creates immediate bidirectional fixation.

Dale Mitchell, President and Founder of Captiva Spine said, “Our design development, incorporating substantial surgeon design input, including dual layer porous 3D printed titanium cages, dates back several years.  The timing for commercialization is excellent, as surgeons’ apparent growing preference for porous 3D printed titanium cages is substantial.  In addition, the recently announced industry acquisitions, that include 3D cage technology, may limit independent distributors’ access to this critical growth technology.  Likewise, we are pleased to make our complete line of TirboLOX 3D printed titanium cages available to support their surgeons’ needs.”  Captiva Spine is able to deliver TirboLOX Cervical’s unique dual layer organic lattice structure with numerous geometries and sizes satisfying a wide range of surgeon preferences.

Captiva Spine’s TirboLOX-C Titanium Cervical Cages are one of five new product launches that will be featured at Booth 1649 during the North American Spine Society (NASS) Annual Meeting held in Los Angles, September 26-28, 2018.

Inquiries from tenured distribution professionals looking to partner with a company to build a relationship for the long run are always welcome.

For sales, contact:
Chip Jones, Director of Sales and Marketing
chip.jones@captivaspine.com or 561-277-9480 ext. 725
or via their website www.captivaspine.com/contact-us.

About Captiva Spine, Inc.

As a privately owned medical device organization founded in 2007, Captiva Spine supports spine surgeons, tenured spine distributors, and healthcare facilities in providing patients with progressive spinal care and an obsessive focus on quality.  They strive to create and maintain sincere, honest, collaborative relationships. By valuing their relationships above all else, it fosters the mutual trust and openness needed for Captiva Spine to be a conduit of high quality, smart, elegant, and intuitive patient solutions. As a family of industry professionals, Captiva Spine takes pride in delivering these solutions responsibly and ethically while never losing sight of what they refer to as the Human Factor: Finding the joy in their daily lives and serving the needs of their customers with sincere, professional enthusiasm.

SEE MORE ABOUT TIRBOLOX-C

This Press Release can be found at PRWeb.com

Captiva Spine TowerLOX-EXT MIS Extended Tab Pedicle Screw

SEE MORE ABOUT TOWERLOX-EXT

Captiva Spine Receives Clearance to Market TowerLOX-EXT Extended Tab Pedicle Screws

Jupiter, FL, September 2018 – Captiva Spine, Inc., which designs, manufactures and distributes elegant and intuitive spine fusion solutions announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market TowerLOX-EXT® MIS Extended Tab Pedicle Screw complementing its TowerLOX® MIS Pedicle Screw System.

TowerLOX-EXT MIS Extended Tab Pedicle Screw

TowerLOX-EXT MIS Extended Tab Pedicle Screws provide the narrow insertion of an extended tab pedicle screw and the versatility, reliability, and security of a tower-based MIS pedicle screw.  TowerLOX-EXT’s narrow insertion path coupled with TowerLOX’s patented articulating rod delivery/reduction options expand the capabilities of the system.  Most notably, TowerLOX-EXT allows percutaneous tower attachment after the extended tabs have been removed, establishing a new standard for MIS pedicle screw systems. This is especially important intraoperatively, or for use when extending the fusion at a later date.

Dale Mitchell, President of Captiva Spine, stated “The design rationale and goals developed with our surgeon collaborators guided the creation of TowerLOX-EXT Extended Tab Pedicle Screw.  Our intent was to reduce insertion pathway, eliminate counter-torque wound expansion, and retain the versatility provided by TowerLOX’s unique instrumentation for rod delivery, rod reduction, and spondylolisthesis reduction.”

TowerLOX® MIS Pedicle Screw System already supports MIS, mini-open, and open cases with simple and less invasive rod insertion (using patented Pivotec® Technology) and efficient internal/external rod reduction. TowerLOX-EXT screws provide 15mm of controlled built-in rod reduction above the break-off and in-situ tower attachment capabilities provide a MIS rescue/revision option not available with other extended tab systems.

Captiva Spine’s TowerLOX-EXT MIS Extended Tab Pedicle Screw is one of five new product launches that will be featured at Booth 1649 during the North American Spine Society (NASS) Annual Meeting held in Los Angeles, September 26-28, 2018.

Inquiries from tenured distribution professionals looking to partner with a company to build a relationship for the long run are always welcome.

For sales, contact:
Chip Jones, Director of Sales and Marketing
chip.jones@captivaspine.com or 561-277-9480 ext. 725
or via their website www.captivaspine.com/contact-us.

About Captiva Spine, Inc.

As a privately owned medical device organization founded in 2007, Captiva Spine supports spine surgeons, tenured spine distributors, and healthcare facilities in providing patients with progressive spinal care and an obsessive focus on quality.  They strive to create and maintain sincere, honest, collaborative relationships. By valuing their relationships above all else, it fosters the mutual trust and openness needed for Captiva Spine to be a conduit of high quality, smart, elegant, and intuitive patient solutions. As a family of industry professionals, Captiva Spine takes pride in delivering these solutions responsibly and ethically while never losing sight of what they refer to as the Human Factor: Finding the joy in their daily lives and serving the needs of their customers with sincere, professional enthusiasm.

This Press Release can be found at PRWeb.com and is also featured on: OrthoSpineNews, Becker’s Spine Review, Spine-Market.com, TheSpineMarketGroup.com

TirboLOX Top View - 50x

Captiva Spine’s TirboLOX-L™ Dual Layer Organic Lattice Structure 3D Printed Titanium Lumbar Cages Receive Clearance

Jupiter, FL, August 2018 – Captiva Spine is a medical device organization located in Jupiter, Florida, dedicated to delivering smart, elegant and intuitive spinal fusion solutions. Today, Captiva Spine is announcing it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its TirboLOX-L 3D Printed Titanium Lumbar Cages.

TirboLOX-L Titanium Lumbar Cages

TirboLOX-L Titanium Lumbar Cages are created using advanced 3D printing technologies to form titanium alloy interbody fusion devices with a dual layer organic lattice structure. This lattice structure features a micro-rough surface topography, interconnected dual porosity, and open architecture.  Titanium alloy implants with micro-rough surface topographies and dual porosity have been shown to promote direct bony ongrowth, ingrowth and vascularization. TirboLOX-L’s open architecture is designed to reduce radiographic presence for clear imaging.  TirboLOX-L’s high coefficient of friction creates immediate bidirectional fixation.

Dennis Ty, Director of R&D of Captiva Spine declared, “With the advanced capabilities of 3D Additive Manufacturing we were able to create a unique lattice structure similar to trabecular bone incorporating a micro-rough surface for clot retention and early osteogenic cell migration, including a dual layer of porosity with pore sizes specifically designed to promote bone ingrowth and vascularization.  Through substantial surgeon design input we are able to deliver TirboLOX-L’s unique dual layer organic lattice structure with numerous geometries and sizes that appeal to a wide range of surgeon preferences.”

Dale Mitchell, President and Founder of Captiva Spine said, “I am pleased our development team was able to incorporate our proprietary Pivotec® Pivoting TLIF Cage into TirboLOX.  Pivotec technology has been used in thousands of surgeries to address the challenges of controlling cage insertion and angle manipulation during surgery and is now available in a wide range of porous Titanium 3D printed, sterile packaged implants. This is especially important during minimally invasive (MIS) applications where time and safety is always of the essence.”

Captiva Spine’s TirboLOX-L Lumbar Cages are one of five new product launches that will be featured at Booth 1649 during the North American Spine Society (NASS) Annual Meeting held in Los Angles, September 26-28, 2018.

Inquiries from tenured distribution professionals looking to partner with a company to build a relationship for the long run are always welcome.

For sales, contact:
info@captivaspine.com or 561-277-9480
or via their website www.captivaspine.com/contact-us.

About Captiva Spine, Inc.

As a privately owned medical device organization founded in 2007, Captiva Spine supports spine surgeons, tenured spine distributors, and healthcare facilities in providing patients with progressive spinal care and an obsessive focus on quality.  They strive to create and maintain sincere, honest, collaborative relationships. By valuing their relationships above all else, it fosters the mutual trust and openness needed for Captiva Spine to be a conduit of high quality, smart, elegant, and intuitive patient solutions. As a family of industry professionals, Captiva Spine takes pride in delivering these solutions responsibly and ethically while never losing sight of what they refer to as the Human Factor: Finding the joy in their daily lives and serving the needs of their customers with sincere, professional enthusiasm.

SEE MORE ABOUT TIRBOLOX-L

This Press Release can be found at PRWeb.com and is also featured on: OrthoSpineNewsHealio,  Becker’s Spine Review,  Spine-Market.com,  Orthoworld, RYOrtho

TransFasten Posterior SI  Fusion System 

Captiva Spine is a medical device organization located in Jupiter, Florida, dedicated to creating sincere and collaborative relationships to deliver smart, elegant, and intuitive spine fusion solutions. Today, Captiva Spine is announcing the alpha launch of the TransFasten Posterior SI Fusion System.  The TransFasten Posterior SI Fusion System was developed in conjunction with Robert Lins, M.D., Orthopedic Spine Surgeon at The Center for Bone & Joint Surgery of the Palm Beaches.

“My goal was to develop a safe and efficient posterior approach potentially reducing operative time, neurovascular complications, and achieving a quadracentric press fit that neither compresses nor expands the sacroiliac joint,” Dr. Lins explained.  “We are creating a fusion site similar to a mortise and tenon joint used in woodworking for thousands of years.” Dr. Lins continued to explain “TransFasten’s streamlined instrumentation and straightforward procedure provide for efficient joint preparation and precise press fit of a QuadraCentric Implant.”


To explain the QuadraCentric Joint Preparation simply…
A) Dock the QuadraCentric Drill Guide at the SI joint.
B) Ream the implant site.
C) Impact the QuadraCentric Implant and graft material.


“The launch of TransFasten (a posterior SI fusion system) is a key milestone in our drive to deliver clinical and economic value for patients, surgeons, and healthcare facilities,” said Dale Mitchell, President and Founder of Captiva Spine.

  • Posterior Approach – Potentially reduces operative time and Neurovascular complications.
  • Posterior Fusion Site Preparation – Allows for efficient preparation of the joint and press fit implant placement.
  • A form of “Mortise and Tenon” Stabilization of the SI Joint (a proven and established method of Architectural Stabilization) – The geometry of the TransFasten implant across the joint is designed to stabilize the motion segment without disrupting the anatomy and creating new pain generators.
  • Structural Allograft Implant – Custom allograft implant includes a large trans-joint graft window for accommodating a biologic fusion.

Training Opportunities Available. Call Captiva Spine direct at 561-277-9480.


Click to Download More Information

Brochure, Surgical Technique, Case Studies and More…

Captiva Spine Marks First Surgeries Using TransFasten™ Posterior SI Fusion System

Captiva Spine, Inc., which designs, manufactures and distributes elegant and intuitive spine device solutions, announces the first surgeries using the company’s proprietary TransFasten™ Posterior SI Fusion System.


Captiva Spine’s thoughtful solutions for the entire spinal column will be on display at the AAOS (American Academy of Orthopaedic Surgeons) Annual Meeting March 7-9, 2018 in New Orleans at booth 4213.


TransFasten Posterior Sacroiliac Joint Fusion System
TransFasten Posterior SI Fusion System

The first cases using the company’s proprietary TransFasten Posterior SI Fusion System were successfully completed across the USA starting in December 2017.  TransFasten’s use of a favorable posterior approach will potentially reduce operative time and neurovascular complications. With proprietary QuadraCentric joint preparation, TransFasten provides multiple implant contact points for biomechanical stability during fusion.  An initial TransFasten surgeon, Dr. Pedro Ramirez, M.D. of Central Florida Neurosurgery Institute, stated “the intuitive TransFasten instrumentation allows me to place the implant accurately, utilizing a safe posterior approach while obtaining a true biologic fusion of the sacroiliac joint.”  Over the past several years there has been a resurgence in the recognition of the SI Joint as a potential source of low back pain as treatment options for SI Joint dysfunction have advanced.  Captiva Spine is committed to launch devices that align clinical and economic outcomes on behalf of all key stakeholders.  TransFasten is on a track for completion of its alpha launch, and Captiva Spine will be training additional surgeons on this posterior SI approach nationwide as early as the end of March 2018.


Inquiries from tenured professionals looking to partner with a company to build a relationship for the long run are always welcome. Captiva Spine can be contacted direct by phone at 561-277-9480 or via their website www.captivaspine.com/contact-us.

Discover Strength Through Connections at www.captivaspine.com.

About Captiva Spine, Inc.
Captiva Spine is a privately owned medical device organization founded in 2007.  Captiva Spine supports spine surgeons, tenured spine distributors, and healthcare facilities in providing patients with progressive spinal care and an obsessive focus on quality; they strive to create and maintain sincere, honest, collaborative relationships. By valuing their relationships, above all else, fosters the mutual trust and openness needed for Captiva Spine to be a conduit of high quality, smart, elegant, and intuitive patient solutions. Captiva Spine operates as a family of industry professionals that take pride in delivering these solutions responsibly and ethically while never losing sight of what they refer to as the Human Factor: Finding the joy in their daily lives and serving the needs of their customers with sincere, professional enthusiasm.


For distribution information, please fill out the form below.

1 + 1 = ?

Barcode UDI compliance captiva spine

udi-unique-device-identifier

UDI Introduction

You may or may not be aware, as of September 24, 2016 the FDA is requiring a unique numeric or alphanumeric code (Unique Device Identification or UDI) on all labels and packaging for Captiva Spine’s implants. UDI applies to all U.S. industry implantable devices and we intend to make this transition as efficient as possible.

The goal is to establish a system to identify medical devices through their distribution and use, via the entire supply chain to point of use with patients.  We have been developing a process over the past few months to achieve this goal in an unobtrusive way to your work flow.

We will share this process with you over the upcoming months to help track these new identifier’s and allow for any questions you have of this new process. In the meantime, we wanted you to have a better understanding of UDI, so we have outlined information below to get the ball rolling.

Thank you for your continued support of Captiva Spine and we continue to be grateful for any opportunity to support your business.

  1. What is UDI?
  2. UDI General Rule
  3. Why are we doing it?
  4. Benefits of Unique Device Identification
  5. Conclusion

1. What is UDI?

A UDI is a unique numeric or alphanumeric code, which acts as a key to certain basic identifying information about a device, such as the name of the manufacturer and the type of device, and may represent certain other information about the device, such as its expiration date and batch or lot number.

  • Identifier/code on device label and packaging (and, in some cases, on the device itself) Two parts:
    • UDI = DI+PI * Device Identifier (DI) (static) – specific to a device version or model
  • Production Identifier(s) (PI) (dynamic) – one or more currently used control/production identifiers that is lot/batch number, serial number, manufacturing date, expiration date
  • If on the label – then needs to be part of the PI’s
  • Not requiring any changes to currently used PI’s

2. UDI General Rule

  • The label* of EVERY medical device (including all IVD’s) must have a UDI.
  • EVERY device package (contains a fixed quantity of a version or model) must have a UDI.
  • Any other approach is an exception to or alternative from these requirements.

3. Why are we doing it?

In keeping with the purpose and intent of the UDI rule, FDA reiterated that

“the goal is to establish a system for the adequate identification of medical devices through their distribution and use, via the entire supply chain to point of use with patients.”

FDA also stated that the direct mark requirement for implants in the proposed was not included in the final rule

“… because it was presumed that implants would be accompanied by their unique device identifier (UDI) label or package with UDI label up to the point of implantation.”

Healthcare providers have a lot to gain by jumping aboard the UDI train. By standardizing and cleansing source data, they can:

  • gain deeper insight into their spend,
  • prevent pricing and/or unit-of-measure errors,
  • level pricing across departments and facilities, and
  • aggregate spend throughout the supply chain.

4. Benefits of Unique Device Identification

When fully implemented, the UDI system may:

  • Allow more accurate reporting, reviewing and analyzing of adverse event reports so that problem devices can be identified and corrected more quickly.
  • Reduce medical errors by enabling healthcare professionals and others to more rapidly and precisely identify a device and obtain important information concerning the characteristics of the device.
  • Enhance the FDA’s analysis of devices on the market by providing a standard and clear way to document device use in electronic health records, clinical information systems, claim data sources and registries. A more robust post-market surveillance system can also be leveraged to support premarket approval or clearance of new devices and new uses of currently marketed devices.
  • Provide a standardized identifier that will allow manufacturers, distributors and healthcare facilities to more effectively manage medical device recalls.
  • Provide a foundation for a global, secure distribution chain, helping to address counterfeiting and diversion and prepare for medical emergencies.
  • Lead to the development of a medical device identification system that is recognized around the world.

5. Conclusion

UDI can fundamentally change and improve the way we all interact with medical devices. It can improve the way we order, purchase, securely distribute and safely and effectively use these devices. It will also inform cost and quality decisions.

But more importantly, it can vastly improve our understanding of devices, through a variety of focused and effective PMS activities, including longitudinal studies. This will allow for better understanding of the long-term safety and effectiveness of specific devices, their overall risk profile, and the use of devices in specific patient populations. And when problems do arise, we will be able to quickly identify and communicate with the affected patients in ways that simply don’t currently exist.

But all of this requires change. It requires device manufacturers to appropriately apply and use UDI on their device(s) and it requires everyone else involved in any aspect of device distribution and use, to adopt and implement systems to manage devices at their UDI level. And we believe that creative people will do all sorts of interesting and useful things based on a device’s UDI. But this will take significant time and resources to do.

However the end goal is well worth it. Just as we can’t even imagine a grocery store today without UPCs and scanners, we will have a hard time remembering the device world before UDI.
______
If you have any specific questions about UDI, any of our products or just want to give us feedback, please contact customer service directly at 561-277-9480.

DISCOVER MORE ABOUT OUR PRODUCTS

______

* This is not original content. These are snippets of the guidelines that have been outlined by the FDA.